| Financial Year |
March 31 2023 |
| Monetary Funds |
395,587,256.71 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,400,000.00 |
| Accounts Receivable |
154,585,197.76 |
| Advances to Suppliers |
57,682,893.99 |
| Other Receivables |
44,709,837.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
418,963,236.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,557,321.67 |
| Total Current Assets |
1,109,485,744.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
19,454,782.07 |
| Fixed Assetes |
343,088,771.42 |
| Under-construction Projects |
10,080,883.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,701,716.03 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,180,665.30 |
| Deferred Income Tax Assets |
57,261.00 |
| Other Non-Current Assets |
3,681,337.97 |
| Sub-Total of Non-Current Assets |
477,844,988.85 |
| Total Assets |
1,587,330,733.00 |
| Short-Term Loans |
215,228,341.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
41,276,000.00 |
| Accounts Payable |
77,942,652.78 |
| Accounts Received In Advance |
2,152,947.74 |
| Employee Compensation Payable |
14,386,988.75 |
| Taxes Payable |
9,057,560.95 |
| Interest Payable |
-- |
| Dividend Payable |
1,465,256.62 |
| Other payables |
60,257,882.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
128,435,463.53 |
| Other Current Liabilities |
5,879,292.32 |
| Sub-Total of Current Liabilities |
654,154,109.46 |
| Long-term Loans |
80,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
57,069,500.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,017,068.01 |
| Deferred Income Tax Liabilities |
7,116,282.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
202,526,324.37 |
| Total Liabilities |
856,680,433.83 |
| Paid-In Capital(Or Share Stock) |
424,861,597.00 |
| Capital Surplus |
930,520,784.86 |
| Surplus Reserve |
24,784,760.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-667,545,839.33 |
| Minority Stockholder's Interest |
20,921,936.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
709,728,362.33 |
| Owner's Equity（Stockholder's Equity） |
730,650,299.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,587,330,733.00 |
